FEAT DAILY NEWSLETTER      Sacramento, California      http://www.feat.org

“Healing Autism: No Finer a Cause on the Planet”

December 4, 2001        News Morgue Search  www.feat.org/search/news.asp

 

RESEARCH

·        Harvard Clinic Scientist Finds Gut/Autism Link,

Like Wakefield Finding

·        Message From Andrew Wakefield

·        Commentary on Andrew Wakefield

·        Letters to the FEAT Newsletter re: Andrew Wakefield

·        Autistic Preschoolers Have Larger Brains,

Faces Are Seen Like Photos

IN MEMORIAM

·        ASA Mourns Passing of Board Member and Dedicated Parent Advocate

 

 

Harvard Clinic Scientist Finds Gut/Autism Link, Like Wakefield Findings

Dr. Timothy Buie, a pediatric gastroenterologist from Harvard/Mass General Hospital has performed over 400 gastrointestinal endoscopies with biopsies, as well as evaluation of digestive enzyme function in children diagnosed with autism and finding a connection. The results of his testing are similar to the observations made by Dr. Andrew Wakefield regarding the presence of chronic inflammation of the intestinal tract, although the incidence was noted to be less frequent in his group.

Dr. Buie announced his findings last Saturday at the Oasis 2001 Conference for Autism in Portland, Oregon, the day before the announcement of Wakefield’s forced departure from Royal Free in the UK.

The biopsy results indicated the presence of chronic inflammation of the digestive tract including esophagitis, gastritis and enterocolitis along with the presence of Iymphoid nodular hyperplasia in 15 of 89 children.  Additionally the results of the enzyme testing of Dr. Buie’s patients paralleled that of Dr. Karoly Horvath and colleagues at the University of Maryland School of Medicine.  Dr. Buie found that the autistic children he examined showed disaccbaride/glucoamylase enzyme levels below normal. Some 55% of these children had lactase deficiencies (which breaks down lactose in milk) as well as deficiencies of the enzyme sucrase (responsible for digestion of table sugar).

The findings also lend support to anecdotal reports of improvement of some autistic children on wheat and dairy (gluten, casein) free diets.  Buie says that Harvard wants to do research into the use of protein enzyme supplements, which aid in the digestion of wheat and milk products for treatment.

Buie echoed the opinion of other a growing number of clinical researchers and practitioners treating autistic patients, “these children are ill, in distress and pain, and not just mentally, neurologically dysfunctional.”

[The FEAT Newsletter will provide more details of Dr. Buie’s research shortly.  For more information on enzyme supplements, contact http://www.gfcfdiet.com/Enzymes.htm#*  This is a non-commercial, parent-run website. –LS]

* * *

 

Message From Andrew Wakefield

[This statement went to Andrew Wakefield’s UK supporters and parents prior to the press announcements regarding his departure from Royal Free and University College Medical School over the weekend.]

In view of your previous financial support for medical research co-ordinated through this charity, I write to inform you of a development which will undoubtedly appear in the press over the next few days.

For some time, the future of the research at the Royal Free has been under threat. However, I am pleased to tell you that I have reached an agreement with the Royal Free and University College Medical School, whereby members of my team, and the research they are conducting, are protected for the future as long as sufficient funds are forthcoming to maintain their salaries.

In return, I will no longer be employed at the Royal Free, but will co-ordinate a broadening of the research effort in order to resolve these issues as swiftly as possible. However, the Medical School will permit me to continue close collaboration with my colleagues in Paediatric Gastroenterology and elsewhere, including full access to all patient records and data, both present and future. This has not been an easy decision, but has been taken in order to safeguard the future of this work.

One great benefit of this arrangement is that I shall no longer have to spend a considerable amount of time in distracting political negotiations with the Medical School and will be able to devote 100% of my effort to the research. I anticipate being offered a research position in another institution once news of this arrangement becomes published, and will inform you of any offers received and accepted in due course.

Until then, please rest assured that the work is continuing apace and that the only material change is that the Medical School will no longer have my name on their establishment or pay my salary.

Should you have any questions, please do not hesitate to contact me. I

suggest that the offices of Visceral, the medical research foundation that

administers, co-ordinates and seeks funding for the projects underway in six

medical schools in Europe and the United States, is the best location at

which to contact me. Although I am physically in Visceral’s offices for only

a few days a month, Robert Sawyer or Nikki Carter should be able to find me

without too much difficulty. Once again, many thanks for your support. Yours

sincerely

Andrew Wakefield FRCS

FRC Path Director, Inflammatory Bowel Disease Study Group Trustee,

Visceral

* * *

 

Commentary on Andrew Wakefield

[By Barbara Loe Fisher, President, National Vaccine Information Center

in the NVIC newsletter.]

http://www.909shot.com

Whenever ignorance, envy, greed and suppression dominate the business of a state (or a profession), there will always be heroes who step forward to challenge the status quo. They are usually individuals who lead ordinary lives until, one day, they are faced with an extraordinary situation and make a conscious decision to do the right thing no matter what price they have to pay.

Andrew Wakefield, a brilliant young British gastroenterologist rising quickly in the ranks of his peers, made a conscious decision in 1997 that he could not turn away from a truth he had discovered during the course of his scientific research, even though he knew it could cost him his career. When he realized the lives of children depended upon his having the courage to refuse to remain silent about the association he found between MMR vaccine and autism, he chose to do what was right instead of do what was safe.

Now he is paying the price being exacted by a scientific profession and militarized public health infrastructure that cannot tolerate independent thought and scientific investigation for fear it will lead to change. Like all those involved in perpetuating totalitarian systems that suppress free thought, expression and action, those who have tried to silence and destroy Andrew Wakefield have only succeeded in revealing to the people how afraid they are of what he has to say.

Dr. Wakefield will not only survive what they have done, he will

triumph over it. The truth about vaccines and neuroimmune damage, like

autism, will shine bright and clear in the end, no matter how many try to

hide it because of the courage of individuals like Andrew Wakefield

* * *

 

Letters to the FEAT Newsletter re: Andrew Wakefield

I am very sorry to hear that Andrew Wakefield has been forced out of his position at the Royal Free. We all know what he has done to target gut/autoimmune dysfunction as a marker of autism and as an avenue for research.

What can we do to support Dr. Wakefield himself? I’ve heard him speak in person and on television and he has impressed me with his honesty, his care and concern for his patients with autism. He is also incredibly brave to take on the British medical establishment virtually alone.

I am concerned that his brave stance has cost him his livelihood and career. There must be something the autism community here in the US can do to help him - at least to write letters of support, etc., if someone has his address. I write to you because the FEAT newsletter, of course, was first with this news and I’m hoping you may have some ideas about how to proceed.

·        Paula Stepankowsky

 

 

Dear Paula,

Wakefield addresses some of your concerns in his message

reproduced above.  You can also reach him by email at

awakefield@rfc.ucl.ac.uk .  This account is at Royal Free so

there’s no way of knowing how long it will remain active. -LS

 

 

This is a sad, sad day for all.  Having met Andy Wakefield, I can tell you that he is one of the few in the medical community whose goals are not at all tainted by establishment’s view of what’s politically correct.  He has not wavered in his quest to find the reasons and eventually a cure for our children.

I am sure that as more and more of the people with power are affected by autism and bowel problems - and this certainly will happen - that Andy will find them at his door asking him for help.

Good luck, Andy.  You are a good man.

·        Eric Einbinder, Dad to Jake and Matt, Latham, NY

 

 

My god! Where the hell do we go from here?  That poor man, he has lost his livelihood for being our voice, and for researching our children because no one else had the guts to do it. Who do we put pressure on to sort this out?

The government is so scared of the truth they think it will all go quiet. Don’t they realise that hospitals from all over send our kids to Andy Wakefield because they don’t have a clue how to treat them, and those kids that haven’t been fortunate to be sent to him, have been treated wrongly and their bowel problems are a hell of a lot worse? This whole thing is outrageous.

I have a son Klae, who is 6 and he was damaged by the MMR. I have five children and only he had the vaccine. My other children are fine, and he is not the youngest and I am not old. I don’t think the government has many excuses left.

A big thank you to Andy Wakefield.

·        Sandra Russell

 

 

 

 

>>> PROFESSORS, TEACHERS, TRAINERS <<<

Autism Continuing Education for

Students Now Available

ADVISE TO SUBSCRIBE TO THE

FEAT Daily Newsletter, NO FEE

For the Knowledge Only, No CEUs

http://www.feat.org/FEATNews

 

 

 

* * *

 

Autistic Preschoolers Have Larger Brains, Faces Seen Like Photos

http://www.eurekalert.org/pub_releases/2001-12/uow-ahl120401.php

Preschool-age children with autism exhibit no difference in brain activity when they are shown photographs of faces displaying different emotions, and their brains are larger than normal, according to new research at the University of Washington’s Autism Center.

The findings were reported at the first International Meeting for Autism Research in San Diego last month by Geraldine Dawson, director of the UW Autism Center and a professor of psychology, and Stephen Dager, UW professor of psychiatry and radiology. The autism meeting was held in conjunction with the annual meeting of the Society for Neuroscience.

Both studies used the same pool of 3- and 4-year-old autistic, developmentally delayed and normally developing children. In Dawson’s study, the children wore bonnets studded with 64 sensors that monitored brain activity. The children were shown photographs depicting fear and a neutral expression. The brains of normally developing and developmentally delayed children exhibited different activity depending on the picture being viewed.  However, the brain activity of the autistic children remained the same when the different pictures were shown.

Dawson said that normally developing infants will notice their mothers’ facial expressions and emotions in the first six months of life and that they are able to recognize emotions from facial expressions by age 7 months. A region of the brain called the amygdala that is associated with emotions seems to be a center for recognizing and reacting to fear.

“The ability to react to fear is either innate in humans or develops very early in life,” she said. “It is a selective advantage for our brains to be able to pick up fear, an ability that comes from our early human ancestors.

“Children with autism do not appear to be able to pick up facial signals and notice other people’s emotions. They can’t read the signals or facial expressions of emotions in a normal way. This tells us the problem with the brain likely emerges very early and involves very basic brain systems, those responsible for encoding emotions.”

Understanding this deficit in reading facial expressions and noticing emotions should help parents understand the behavior of their autistic child and why the child doesn’t respond with empathy for others, according to Dawson.

“It also points to the importance of interventions, such as behavioral interventions that reward children for paying attention to facial cues.  Computer programs are being developed at the UW that help children pay attention to proper cues and teach them what facial signals mean,” she said.

New research at the UW Autism Center is finding out how much impact early intervention programs have with these recognition systems and whether they can help rewire the brain to process faces and emotions more normally.  Dager’s work found that the amygdala is disproportionately larger in preschool autistic children than in normally developing and mentally retarded youngsters.

“We looked both at brain structure and brain chemistry, using a specialized form of magnetic resonance imaging called PEPSI, or Proton Echo Planar Spectroscopic Imaging, that was developed at the UW,” Dager said. “We measured the volumes of different regions of the brain and found that the kids with autism had about 10 percent bigger brains on average.”

Dager added that both boys and girls with autism exhibited increased brain volume, in comparison to normally developing children of the same gender. Typically human males have larger brains than females, but Dager says that bigger is not necessarily better.

“Additional studies that we are conducting measuring brain chemistry suggest that the brain cellular composition is altered in the autistic children. This is potentially a very important finding, although we are still trying to better understand the functional significance of these abnormalities,” Dager said.

He said it’s puzzling that this region of the brain that is so closely involved with the normal expression of emotion should be enlarged in this particular group of children who have difficulty expressing normal emotional engagement.

Dager and his colleagues also are trying to determine what enlargement of the amygdala means in relationship to the clinical course or prognosis of autism and how brain developmental processes these children undergo as they grow older affect their brain chemistry. The children are being studied at ages 6 and 9 to evaluate the progression of these brain structural and chemical findings.

Dager cautions that enlargement of the amygdala or of the brain in general cannot be used as a diagnostic tool to determine if a child has autism.

* * *

 

ASA Mourns Passing of Board Member and Dedicated Parent Advocate

[From the Autism Society of America.]

It is with deep regret that we announce that ASA and ASA Foundation Board Member Laura Robertson passed away on December 3, 2001. Laura, who was 53, died unexpectedly, but quietly in her sleep while on vacation.

She is survived by her husband of 32 years, Talbot (“Tal”), and her sons Turner, 24, who has autism, and Lane, 19.

Laura will be remembered for her tireless work on behalf of the autism cause at the local, state, and national levels and for her caring and warm personality.

“Laura was among the most devoted ASA members I have ever met. Her wit, her passion for the Autism cause, her love for her children and her love and respect for her husband were inspiring to me. Words cannot describe the loss I feel and how much I will miss her,” ASA President Lee Grossman said today.

Laura was a member of the national boards of both the ASA and the ASA Foundation. She was elected to the ASA board in 1998, and served as chair of the conference committee for two years, and as 2nd vice president since July 2001. She also served on the board of the ASA Foundation, a position to which she was appointed in 2000.

Laura was also involved in the Acadian Chapter of the ASA in Lafayette, Louisiana, for more than 16 years, including 11 years as chapter president, as well as other leadership roles. In addition, she was a member of the board of the Louisiana State Chapter of the ASA for many years, as well as a member of the Louisiana State Planning Council on Developmental Disabilities and on various committees and task forces within the council.

“Laura was always proud of her southern heritage and never attended a board meeting without a generous supply of local cookies and sweets. I will miss her happy and positive presence and her friendship. The Autism community has lost a very special person,” Robert Beck, executive director of the ASA, said.

In addition to her leadership roles, Laura was a hands-on advocate on behalf of autism and anyone in need. She participated in autism awareness training for staff and parents at schools across Louisiana, helped raise funds at the local and state levels, was involved in due-process training for individuals with autism and other disabilities, and volunteered her time with the local junior league.

When she wasn’t fighting for the cause, Laura, a trained chef, enjoyed entertaining and spending time with her family and friends.

She will be missed by all who knew her.

Information about memorial services and donations will follow as soon

as it is available.

 

 

 

>> DO SOMETHING ABOUT AUTISM NOW <<

Subscribe, Read, then Forward the FEAT Daily Newsletter.

To Subscribe go to    www.feat.org/FEATnews     No Cost!

 

Lenny Schafer, Editor@feat.org    CALENDAR EVENTS@feat.org Michelle Guppy

Catherine Johnson PhD    Ron Sleith    Kay Stammers    Edward Decelie

UNSUBSCRIBE: FEATNews-signoff-request@LIST.FEAT.ORG

 

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.